Endocrinology, Vol 130, 497-502, Copyright © 1992 by Endocrine Society

ARTICLES

Tissue distribution and regulation of insulin-like growth factor (IGF)- binding protein-3 messenger ribonucleic acid (mRNA) in the rat: comparison with IGF-I mRNA expression

AL Albiston and AC Herington
Prince Henry's Institute of Medical Research, Melbourne, Victoria, Australia.

Insulin-like growth factor-binding protein-3 (IGFBP-3) is the most abundant IGFBP in rat and human sera. The present study demonstrates the expression of the rat IGFBP-3 gene in a large number of tissues and coexpression, but not necessarily equal expression, with IGF-I mRNA. Tissues with a major abundance of IGFBP-3 were kidney, antrum of stomach, placenta, uterus, and liver. Changes in hepatic and renal levels of IGFBP-3 mRNA were analyzed after hypophysectomy (with and without GH treatment) and in the developing postnatal rat. These results were compared to changes in IGF-I mRNA levels under the same physiological conditions. Using S1 nuclease analysis, IGFBP-3 mRNA was present in the kidney and liver of 1-day-old rats and rose significantly in both organs by week 1. Thereafter, levels remained relatively constant, particularly in the liver. This is in marked contrast to the hepatic IGF-I pattern, which showed a continual rise up to 8 weeks. Hepatic IGFBP-3 gene expression was partially GH dependent, with IGFBP-3 mRNA levels falling (approximately 50%) after hypophysectomy and rising slightly after GH treatment. These changes were much less dramatic than those in IGF-I mRNA. In contrast, the renal levels of IGFBP-3 mRNA increased after hypophysectomy, (approximately 100%), but did not decrease with GH treatment. These data suggest that IGFBP-3 mRNA abundance is regulated differently in different tissues, and in at least some tissues is less sensitive to regulation than is IGF-I mRNA.

This article has been cited by other articles:

				P. M. Pereira-Fantini, S. L. Thomas, R. G. Taylor, E. Nagy, M. Sourial, P. J. Fuller, and J. E. Bines Colostrum Supplementation Restores Insulin-like Growth Factor -1 Levels and Alters Muscle Morphology Following Massive Small Bowel Resection JPEN J Parenter Enteral Nutr, May 1, 2008; 32(3): 266 - 275. [Abstract] [Full Text] [PDF]

				A. W. Knott, R. J. Juno, M. D. Jarboe, S. A. Profitt, C. R. Erwin, E. P. Smith, J. A. Fagin, and B. W. Warner Smooth muscle overexpression of IGF-I induces a novel adaptive response to small bowel resection Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G562 - G570. [Abstract] [Full Text] [PDF]

				C. A. Shoubridge, C.-B. Steeb, and L. C. Read IGFBP mRNA expression in small intestine of rat during postnatal development Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1378 - G1384. [Abstract] [Full Text] [PDF]

				P. J. D. Delhanty, C. D. Scott, S. Babu, and R. C. Baxter Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E287 - E295. [Abstract] [Full Text] [PDF]

				R. N. N. Han, V. K. M. Han, S. Buch, B. A. Freeman, M. Post, and A. K. Tanswell Insulin-like growth factor binding proteins in air- and 85% oxygen-exposed adult rat lung Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L647 - L656. [Abstract] [Full Text] [PDF]

				Z. S. Gucev, Y. Oh, K. M. Kelley, J. I. Labarta, P. Vorwerk, and R. G. Rosenfeld Evidence for Insulin-Like Growth Factor (IGF)-Independent Transcriptional Regulation of IGF Binding Protein-3 by Growth Hormone in SKHEP-1 Human Hepatocarcinoma Cells Endocrinology, April 1, 1997; 138(4): 1464 - 1470. [Abstract] [Full Text] [PDF]

				E. Melian, B. Velasco, R. Barrios, and F. Sanchez-Franco Basal and Growth Hormone-Induced Hepatic Messenger Ribonucleic Acid Expression of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Is Independent of Hyperinsulinemia and Increased Energy Status in the Genetically Obese Zucker Rat Endocrinology, March 1, 1997; 138(3): 1066 - 1071. [Abstract] [Full Text] [PDF]

				B. C. Villafuerte, W. Zhao, A. C. Herington, R. Saffery, and L. S. Phillips Identification of an Insulin-responsive Element in the Rat Insulin-like Growth Factor-binding Protein-3 Gene J. Biol. Chem., February 21, 1997; 272(8): 5024 - 5030. [Abstract] [Full Text] [PDF]

				Y. J. H. Janssen, M. Frolich, and F. Roelfsema A Low Starting Dose of Genotropin in Growth Hormone-Deficient Adults J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 129 - 135. [Abstract] [Full Text] [PDF]

				M. Thoren, A. Hilding, R. C. Baxter, M. Degerblad, I.-L. Wivall-Helleryd, and K. Hall Serum Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit as Serum Markers of Body Composition during Growth Hormone (GH) Therapy in Adults with GH Deficiency J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 223 - 228. [Abstract] [Full Text] [PDF]

				I. Ueki, G. T. Ooi, M. L. Tremblay, K. R. Hurst, L. A. Bach, and Y. R. Boisclair Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system PNAS, June 6, 2000; 97(12): 6868 - 6873. [Abstract] [Full Text] [PDF]